1. Home
  2. LBRT vs MIRM Comparison

LBRT vs MIRM Comparison

Compare LBRT & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Energy Inc.

LBRT

Liberty Energy Inc.

HOLD

Current Price

$24.49

Market Cap

4.1B

Sector

Energy

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$100.78

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRT
MIRM
Founded
2011
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.2B
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
LBRT
MIRM
Price
$24.49
$100.78
Analyst Decision
Buy
Strong Buy
Analyst Count
12
11
Target Price
$22.08
$102.64
AVG Volume (30 Days)
5.2M
733.0K
Earning Date
01-28-2026
02-26-2026
Dividend Yield
1.47%
N/A
EPS Growth
N/A
N/A
EPS
0.89
N/A
Revenue
$4,006,116,000.00
$471,794,000.00
Revenue This Year
N/A
$55.91
Revenue Next Year
$9.99
$23.97
P/E Ratio
$27.48
N/A
Revenue Growth
N/A
53.66
52 Week Low
$9.50
$36.88
52 Week High
$27.21
$105.74

Technical Indicators

Market Signals
Indicator
LBRT
MIRM
Relative Strength Index (RSI) 60.59 64.68
Support Level $24.13 $97.49
Resistance Level $25.91 $105.74
Average True Range (ATR) 1.63 3.71
MACD 0.00 -0.79
Stochastic Oscillator 58.94 62.01

Price Performance

Historical Comparison
LBRT
MIRM

About LBRT Liberty Energy Inc.

Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: